Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
暂无分享,去创建一个
[1] E. Stiliaris,et al. 99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models , 2022, Nanomaterials.
[2] Arifudin Achmad,et al. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker , 2022, Molecules.
[3] Jianhua Liu,et al. ES-MION-Based Dual-Modality PET/MRI Probes for Acidic Tumor Microenvironment Imaging , 2022, ACS omega.
[4] M. Gazouli,et al. Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging , 2021, Nanomaterials.
[5] D. Stamopoulos,et al. Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles , 2021, Scientific Reports.
[6] Yan Fang,et al. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo , 2021, Acta pharmaceutica Sinica. B.
[7] P. Gawne,et al. Radiolabelling of nanomaterials for medical imaging and therapy. , 2021, Chemical Society reviews.
[8] D. Stamopoulos,et al. Hemocompatibility of gallium-68 labeled iron oxide nanoparticles coated with 2,3-dicarboxypropane-1,1-diphosphonic acid. , 2020, Materials science & engineering. C, Materials for biological applications.
[9] A. Lahooti,et al. Development of radiolabeled dextran coated iron oxide nanoparticles with 111-In and its biodistribution studies , 2020 .
[10] P. Geramifar,et al. Development of Ga-68 radiolabeled DOTA functionalized and acetylated PAMAM dendrimer-coated iron oxide nanoparticles as PET/MR dual-modal imaging agent , 2020 .
[11] G. Bormans,et al. Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution , 2020, EJNMMI Research.
[12] O. K. Guldu,et al. 89Zr Labeled Fe3O4@TiO2 Nanoparticles: In Vitro Afffinities with Breast and Prostate Cancer Cells. , 2020, Applied organometallic chemistry.
[13] P. Geramifar,et al. Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe. , 2020, International journal of biological macromolecules.
[14] S. Vranješ-Đurić,et al. 99mTc-bisphosphonate-coated magnetic nanoparticles as potential theranostic nanoagent. , 2019, Materials science & engineering. C, Materials for biological applications.
[15] P. Geramifar,et al. 68Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation , 2019, International journal of nanomedicine.
[16] John Kurhanewicz,et al. Hyperpolarized 13C MRI: State of the Art and Future Directions. , 2019, Radiology.
[17] Xudong Shi,et al. Integrin αvβ3 receptor targeting PET/MRI dual-modal imaging probe based on the 64Cu labeled manganese ferrite nanoparticles. , 2018, Journal of inorganic biochemistry.
[18] A. Harris,et al. A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis , 2018, Front. Chem..
[19] M. Brtnický,et al. Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy , 2018, Advanced healthcare materials.
[20] J. Vanek,et al. NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies. , 2018, Inorganic chemistry.
[21] S. Toma,et al. Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging , 2018, Pharmaceutical Research.
[22] M. Gazouli,et al. Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study , 2017, Contrast media & molecular imaging.
[23] S. Laurent,et al. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications , 2017, Advanced healthcare materials.
[24] C. Ingvar,et al. Combined Magnetomotive ultrasound, PET/CT, and MR imaging of 68Ga-labelled superparamagnetic iron oxide nanoparticles in rat sentinel lymph nodes in vivo , 2017, Scientific Reports.
[25] Heng Zhao,et al. MR/SPECT Imaging Guided Photothermal Therapy of Tumor-Targeting Fe@Fe3O4 Nanoparticles in Vivo with Low Mononuclear Phagocyte Uptake. , 2016, ACS applied materials & interfaces.
[26] A. Lahooti,et al. Development of 177Lu-DTPA-SPIO conjugates for potential use as a dual contrast SPECT/MRI imaging agent , 2016 .
[27] Dong Soo Lee,et al. Development of a complementary PET/MR dual-modal imaging probe for targeting prostate-specific membrane antigen (PSMA). , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[28] P. Geramifar,et al. PEGylated superparamagnetic iron oxide nanoparticles labeled with 68Ga as a PET/MRI contrast agent: a biodistribution study , 2016, Journal of Radioanalytical and Nuclear Chemistry.
[29] Christopher Cawthorne,et al. Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactions. , 2015, Nanoscale.
[30] D. Abou,et al. Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation , 2015, The British journal of radiology.
[31] M. Mahmoudi,et al. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo. , 2015, Contrast media & molecular imaging.
[32] Zhen Yuan,et al. PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. , 2015, Quantitative imaging in medicine and surgery.
[33] M. Hur,et al. Synthesis and characterization of 68Ga labeled Fe3O4 nanoparticles for positron emission tomography (PET) and magnetic resonance imaging (MRI) , 2015, Journal of Radioanalytical and Nuclear Chemistry.
[34] Lu Zhang,et al. MRI/SPECT/Fluorescent Tri‐Modal Probe for Evaluating the Homing and Therapeutic Efficacy of Transplanted Mesenchymal Stem Cells in a Rat Ischemic Stroke Model , 2015, Advanced functional materials.
[35] Hossein Afarideh,et al. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles. , 2015, Nuclear medicine and biology.
[36] Bin Zhang,et al. Radiolabeled cyclic arginine-glycine-aspartic (RGD)-conjugated iron oxide nanoparticles as single-photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) dual-modality agents for imaging of breast cancer , 2015, Journal of Nanoparticle Research.
[37] George Loudos,et al. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment. , 2014, Journal of colloid and interface science.
[38] R. Sabaté,et al. Potential applications of magnetic particles to detect and treat Alzheimer's disease , 2014, Nanoscale Research Letters.
[39] M. Meyerand,et al. Intrinsically Germanium‐69‐Labeled Iron Oxide Nanoparticles: Synthesis and In‐Vivo Dual‐Modality PET/MR Imaging , 2014, Advanced materials.
[40] Hanno Schieferstein,et al. Radiolabeling of Nanoparticles and Polymers for PET Imaging , 2014, Pharmaceuticals.
[41] T. Hyeon,et al. Paramagnetic inorganic nanoparticles as T1 MRI contrast agents. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[42] Yan Xing,et al. Radiolabeled Nanoparticles for Multimodality Tumor Imaging , 2014, Theranostics.
[43] Jan Grimm,et al. Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle , 2014, Nature Communications.
[44] Stephen J. Archibald,et al. Final step gallium-68 radiolabelling of silica-coated iron oxide nanorods as potential PET/MR multimodal imaging agents. , 2014, Faraday discussions.
[45] Hui Tan,et al. Design and preliminary assessment of 99mTc-labeled ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/magnetic resonance imaging of hepatocellular carcinoma , 2014, Journal of Radioanalytical and Nuclear Chemistry.
[46] C. Cho,et al. Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. , 2013, Biotechnology advances.
[47] Eun Kyoung Ryu,et al. Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle. , 2013, Biomaterials.
[48] N. P. Ulrih,et al. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. , 2013, Cancer letters.
[49] In-Kyu Park,et al. Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer , 2013, International journal of molecular sciences.
[50] Wei Wang,et al. Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging. , 2013, Nanoscale.
[51] Heather M. Hennkens,et al. Radiometals for combined imaging and therapy. , 2013, Chemical reviews.
[52] René M. Botnar,et al. Bisphosphonate-Anchored PEGylation and Radiolabeling of Superparamagnetic Iron Oxide: Long-Circulating Nanoparticles for in Vivo Multimodal (T1 MRI-SPECT) Imaging , 2012, ACS nano.
[53] Michael S. Hofman,et al. Is there still a role for SPECT–CT in oncology in the PET–CT era? , 2012, Nature Reviews Clinical Oncology.
[54] Patrick Couvreur,et al. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. , 2012, Chemical reviews.
[55] D. Meier,et al. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[56] Abass Alavi,et al. Emerging role of radiolabeled nanoparticles as an effective diagnostic technique , 2012, EJNMMI Research.
[57] Linda Knutsson,et al. 99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes , 2012, The Journal of Nuclear Medicine.
[58] Taeghwan Hyeon,et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. , 2011, Journal of the American Chemical Society.
[59] G. Glover. Overview of functional magnetic resonance imaging. , 2011, Neurosurgery clinics of North America.
[60] Andrea Protti,et al. (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. , 2011, Bioconjugate chemistry.
[61] É. Tóth,et al. Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. , 2010, Inorganic chemistry.
[62] D. Stamopoulos,et al. On the biocompatibility of Fe3O4 ferromagnetic nanoparticles with human blood cells. , 2010, Journal of nanoscience and nanotechnology.
[63] Forrest M Kievit,et al. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. , 2010, ACS nano.
[64] Ambika Bumb,et al. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. , 2010, Chemical reviews.
[65] J. Zubieta,et al. Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era. , 2010, Chemical reviews.
[66] Kai Chen,et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.
[67] Michael J. Welch,et al. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. , 2010, Bioconjugate chemistry.
[68] Miqin Zhang,et al. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.
[69] T. Yen,et al. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. , 2010, Biomaterials.
[70] Mark E. Davis,et al. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.
[71] S. Mather,et al. Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases. , 2009, Chemical communications.
[72] Mingyuan Gao,et al. A novel type of dual-modality molecular probe for MR and nuclear imaging of tumor: preparation, characterization and in vivo application. , 2009, Molecular pharmaceutics.
[73] D. Benaki,et al. Biocompatibility and Solubility of Fe3O4-BSA Conjugates with Human Blood , 2009 .
[74] D. Benaki,et al. Bare and protein-conjugated Fe3O4 ferromagnetic nanoparticles for utilization in magnetically assisted hemodialysis: biocompatibility with human blood cells , 2008, Nanotechnology.
[75] Jerry S. H. Lee,et al. Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.
[76] Chenjie Xu,et al. PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.
[77] Pius August Schubiger,et al. Molecular imaging with PET. , 2008, Chemical reviews.
[78] Christian Bergemann,et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.
[79] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[80] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[81] Chao-Ming Fu,et al. Directly labeling ferrite nanoparticles with Tc-99m radioisotope for diagnostic applications , 2004, IEEE Transactions on Magnetics.
[82] R. Müller,et al. A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The In Vivo Behaviour , 2002, Journal of drug targeting.
[83] R Weissleder,et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.